UiPath Inc. (PATH) - Stock Analysis
Last updated: Apr 12, 2026
Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Strong Q3 fiscal 2026 ARR growth (11% YoY), AI partnerships, and a ~30% price surge with positive technical breakout highlight UiPathâs accelerating automation momentum, framing it as a high-conviction short-term buy despite governance and macro risks.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Strong liquidity ⢠High gross margin ⢠Heavy operating spend PATH has strong liquidity, very high gross margins and improving quarterly profitability but is weighed down by heavy operating/R&D spend, large deferred-revenue concentration and elevated valuation.
Price Behavior
Key Price Behavior Insights: ⢠Downward pressure ⢠Oversold momentum ⢠Key support test Support Level: $9.38 (intermediate $9.94) Resistance Level: $11.20 (prior swing $12.13â$12.45) PATH is in a clear short-term downtrend: trading well below last month's SMA (~$11.20) with price at $9.38 (recent low) and RSI ~19 signaling oversold conditions that could produce a short mean-reversion bounce but a break below $9.38 would extend the decline.
Sentiment & News
Key News Insights: ⢠Revenue & margins ⢠AgenticâAI wins ⢠Strong balance sheet UiPath shows accelerating revenue and margin improvement driven by agenticâAI product wins, strong cash/debtâfree balance sheet and buybacks, but shares remain ~30% off amid sentimentâled valuation compression.
AI Summary
PATH has materially de-risked into a cash-rich, margin-improving, product-led operator where the primary upside now hinges on executing agenticâAI monetization to re-accelerate ARR and sustain ~30% nonâGAAP margins â watch for consecutive quarters of ARR expansion or clear netânew bookings from Deloitte/Microsoft/WorkFusion integrations as the binary catalyst, because failure to deliver would quickly compress valuation given limited downside cushion.
Description
UiPath Inc. sells an end-to-end robotic process automation platform that helps organizations design, deploy and govern software robots and related machine-learning models, with major operations in the United States, Romania and Japan. The platform combines AI-driven process discovery, low-code development, orchestration for attended and unattended bots, application connectors and centralized tools for testing, monitoring and compliance; the company also offers maintenance, training and implementation services. Customers include banks, healthcare providers, financial services firms and government agencies; the company was founded in 2005 and is headquartered in New York, NY.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Dec 8 | Dec 15 | PATH | UiPath Inc. | Strong Q3 fiscal 2026 ARR growth (11% YoY), AI partnerships, and a ~30% price surge with positive technical breakout highlight UiPathâs accelerating automation momentum, framing it as a high-conviction short-term buy despite governance and macro risks. | Closed | -16.2% |